The Digest for Health Transformers & Changemakers
From venture capital to executive insights to AI workshops and demos, we have exciting events happening inside the community in the months ahead.
“This Fireside Chat is a brilliant practical discussion. Thank you for being clear and direct — it's most helpful.”
Alexandra Greenhill, MD
CEO, Chief Medical Officer, and Co-founder, Careteam Technologies
Member since 2017
“Thank you for the expert session yesterday! I didn't even know I needed it until I realized mid-session that I needed it.”
Shireen Abdullah
CEO & Founder, Yumlish
Member since 2019
“Thank you for everything that StartUp Health is doing for the ecosystem. We had a reception yesterday for the Alzheimer's Moonshot and I got to meet all the other companies and founders, and it's really a great community and we're already working on ideas on how to work together and collaborate.”
Bill Uniowski
CEO & Co-founder, Zinnia
Member since 2024
From molecular design to pharmacy automation, this week's raises span coasts and continents – a $400M mega-round out of San Francisco, senior care innovation in New York, and early-stage bets on obesity care, clinical trial AI, and cross-border telehealth stretching from Madrid to Milan to London.
📈 Read on Health Transformer Journal
Yuling Luo, PhD, CEO, Founder & Chairman of Alamar Biosciences, on the company partnering with leading research universities to launch a national initiative advancing blood-based biomarkers for neurodegenerative diseases.
🔗 Read
Mike Banville, CEO of ALZpath, on data highlighting the company’s proprietary pTau217 antibody being featured in 86 scientific presentations from 56 leading academic, clinical, and industry organizations at the Alzheimer's Association International Conference (AAIC) this week.
🔗 Read
Jussi Määttä, CEO & Co-founder of Buddy Healthcare, on the company’s acquisition by VitalHub, adding a digital backdoor solution that fills a gap in VitalHub’s existing patient flow suite.
🔗 Read
Stephen Willard, CEO, and Joshua Hare, MD, Founder, Chair, & Chief Science Officer of Longeveron, on clinical data that indicate the company’s cellular therapy, laromestrocel, reduced neuroinflammation in patients with Alzheimer’s disease.
🔗 Read
Paul Campbell and Jen Flexman, PhD, Co-founders of Moneta Health, on the results from a new study of the company’s telephone-based "physical therapy for the brain" program showing outcomes meeting or exceeding national in-person benchmarks.
🔗 Read
Help Us Spread the Word
When you shoot for the Moon, it’s important to surround yourself with people who help you get there.
Thank you for being part of StartUp Health’s global community leaning into health innovation. If you found this newsletter valuable, chances are others will too, so please feel free to pass it along.
And if you or your organization are interested in supporting this work through sponsorship or partnership, we’d love to hear from you. You can schedule a newsletter ad placement or check out our sponsorship opportunities. We also invite you to use our affiliate link to join us on Beehiiv, our new newsletter platform.
